UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000044956
Receipt No. R000051349
Scientific Title Efficacy of metacognitive training for long-term hospitalized patients with schizophrenia
Date of disclosure of the study information 2021/07/27
Last modified on 2021/07/26 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Efficacy of metacognitive training for long-term hospitalized patients with schizophrenia
Acronym Efficacy of metacognitive training for long-term hospitalized patients with schizophrenia
Scientific Title Efficacy of metacognitive training for long-term hospitalized patients with schizophrenia
Scientific Title:Acronym Efficacy of metacognitive training for long-term hospitalized patients with schizophrenia
Region
Japan

Condition
Condition schizophrenia
Classification by specialty
Psychiatry
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the effectiveness of metacognitive training (MCT) in long-term hospitalized patients with schizophrenia by comparing it with the usual care group.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Japanese version of Montreal Cognitive Assessment (MoCA-J)
Key secondary outcomes Positive and Negative Syndrome Scale (PANSS)
Beck Cognitive Insight Scale (BCIS-J)
Global Assessment of Functioning (GAF)

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification YES
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking YES
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Other
Interventions/Control_1 MCT will be introduced once a week in addition to regular occupational therapy for a total of 16 sessions.
The target group will receive regular occupational therapy.
Interventions/Control_2 Assign two groups: intervention group and target group.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <
Age-upper limit
80 years-old >
Gender Male and Female
Key inclusion criteria 1) Patients who have been hospitalized at
Uematsu Hospital for more than one year
(2) Patients with a diagnosis of schizophrenia
(3) Patients undergoing occupational therapy
(4) Patients who have given written consent to participate in this study based on their own free will after receiving sufficient explanation.
Key exclusion criteria 1) Patients under 20 years old.
2) Intellectual disability. Patients with complications such as alcohol or drug dependence, dementia, epilepsy, head trauma, cerebrovascular disease, etc.
3) Patients who have difficulty in performing MCT.
4) Patients who are not receiving occupational therapy.
(5) Patients who cannot give consent to participate in the study
6) Patients who are judged ineligible by the attending physician or principal investigator
Target sample size 60

Research contact person
Name of lead principal investigator
1st name Masayoshi
Middle name
Last name Kobayashi
Organization Shinshu University
Division name Graduate School of General Medical Science and Engineering
Zip code 390-8621
Address Nagano,Matsumoto,asahi 3-1-1
TEL 0263372403
Email mkobaya@shinshu-u.ac.jp

Public contact
Name of contact person
1st name Rumi
Middle name
Last name Sunohara
Organization NAGANO UNIVERSITY OF HEALTH AND MEDICINE
Division name Department of Rehabilitation, Faculty of Health Sciences
Zip code 380
Address Nagano,Nagano.Kawanakajima-machi,Imaihara11-1
TEL 026-283-6111
Homepage URL
Email sunohara.rumi@shitoku.ac.jp

Sponsor
Institute Shinshu University
Institute
Department

Funding Source
Organization Shinshu University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Ethics Committee ,Shinshu University School of Medicine
Address Nagano,Matsumoto,Asahi 3-1-1
Tel 0263-37-2572
Email mdrinri@shinshu-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 上松病院(長野県)

Other administrative information
Date of disclosure of the study information
2021 Year 07 Month 27 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2021 Year 06 Month 10 Day
Date of IRB
2021 Year 06 Month 11 Day
Anticipated trial start date
2021 Year 08 Month 17 Day
Last follow-up date
2022 Year 08 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 07 Month 26 Day
Last modified on
2021 Year 07 Month 26 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051349